The need for public education on HPV and cervical cancer prevention in Asia Opinions of experts at the AOGIN Conference

被引:20
作者
Garland, S. [1 ,2 ]
Park, S. N. [3 ]
Ngan, H. Y. S. [4 ]
Frazer, I. [5 ]
Tay, E. H. [6 ]
Chen, C. J. [7 ]
Bhatla, N. [8 ]
Pitts, M. [9 ]
Shin, H. R. [10 ,11 ]
Konno, R. [12 ]
Smith, J. [13 ]
Pagliusi, S. [14 ]
Park, J. S. [15 ]
机构
[1] Royal Hosp Women, Dept Microbiol & Infect Dis, Carlton, Vic 3053, Australia
[2] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia
[3] KFDA, NITR, Div Genet Toxicol, Seoul 122704, South Korea
[4] Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Gynaecol Oncol Div, Hong Kong, Hong Kong, Peoples R China
[5] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Woolloongabba, Qld 4102, Australia
[6] KK Womens & Childrens Hosp, Singapore 229899, Singapore
[7] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan
[8] All India Inst Med Sci, Dept Obstet & Gynaecol, New Delhi 110029, India
[9] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic 300, Australia
[10] Natl Canc Ctr, Natl Canc Control Res Inst, Canc Prevent Div, Goyang, South Korea
[11] Int Agcy Res Canc, Data Anal & Interpretat Grp, F-69372 Lyon, France
[12] Jichi Med Univ, Dept Obstet & Gynecol, Saitama Med Ctr, Omiya Ku, Saitama 3308503, Japan
[13] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA
[14] WHO, Formerly Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland
[15] Catholic Univ Korea, Kangnam St Marys Hosp, Dept Obstet & Gynecol, AOGIN, Seoul 137040, South Korea
关键词
Cervical cancer prevention; HPV vaccines; Cervical screening; Public health education;
D O I
10.1016/j.vaccine.2008.07.077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Asia accounts for more than half of all cases of cervical cancer registered globally and improving prevention is urgently needed. A range of tools and strategies is now available to effectively prevent this disease, including two new Prophylactic HPV vaccines approved and recommended for adolescents and young women. However, without communication these tools may have little impact on disease burden. The conferences of the Asia Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN) bring together clinicians and scientists whose work is related to genital infections, particularly HPV, cervical dysplasia and neoplasia, as well as other anogenital cancers, with the aim of improving communication on prevention through human papillomavirus (HPV) vaccination and screening in Asian countries. The scope of this year's AOGIN conference was to extend education to include health workers, family doctors, paediatricians, governmental health agencies, and the general public through patients' testimonials that can reach Out to women raising awareness of this silent disease. Community based initiatives and awareness campaigns were also reported, and can empower the people to engage in a dialog with local governments towards prioritization of cancer prevention programs, achieving more for the public than isolated actions. Parents and teachers are encouraged to communicate about these issues within families and schools. Evidence was discussed that males can participate in cervical cancer control as well, and prevention programs involving men should not be neglected as they may reduce genital disease burden in women. Opinion leaders proposed prevention measures to be considered for governmental decisions. While each country develops a locally appropriate policy for cervical cancer control there is a need to revise these Programs regularly, as knowledge increases in response to public need, as well as to gather evidence about disease burden and the effectiveness of education and interventions. In conclusion, AOGIN is committed to improve communication with patients, health authorities, professional organizations and opinion leaders towards strengthening cervical cancer prevention in Asia, to achieve a timely steep reduction in this cancer.
引用
收藏
页码:5435 / 5440
页数:6
相关论文
共 15 条
[1]  
Bhatla Neerja, 2007, Indian Journal of Cancer, V44, P51
[2]   Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study [J].
Brabin, Loretta ;
Roberts, Stephen A. ;
Stretch, Rebecca ;
Baxter, David ;
Chambers, Gloria ;
Kitchener, Henry ;
McCann, Rosemary .
BRITISH MEDICAL JOURNAL, 2008, 336 (7652) :1056-1058
[3]   Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening [J].
Bray, F ;
Loos, AH ;
McCarron, P ;
Weiderpass, E ;
Arbyn, M ;
Moller, H ;
Hakama, M ;
Parkin, DM .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (03) :677-686
[4]   Nationwide hepatitis B vaccination program in Taiwan: Effectiveness in the 20 years after it was launched [J].
Chien, Yin-Chu ;
Jan, Chyi-Feng ;
Kuo, Hsu-Sung ;
Chen, Chien-Jen .
EPIDEMIOLOGIC REVIEWS, 2006, 28 :126-135
[5]   Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea [J].
Clifford, Gary M. ;
Shin, Hai-Rim ;
Oh, Jin-Kyoung ;
Waterboer, Tim ;
Ju, Young-Hee ;
Vaccarella, Salvatore ;
Quint, Wim ;
Pawlita, Michael ;
Franceschi, Silvia .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (09) :1874-1879
[6]   Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases [J].
Garland, Suzanne M. ;
Hernandez-Avila, Mauricio ;
Wheeler, Cosette M. ;
Perez, Gonzalo ;
Harper, Diane M. ;
Leodolter, Sepp ;
Tang, Grace W. K. ;
Ferris, Daron G. ;
Steben, Marc ;
Bryan, Janine ;
Taddeo, Frank J. ;
Railkar, Radha ;
Esser, Mark T. ;
Sings, Heather L. ;
Nelson, Micki ;
Boslego, John ;
Sattler, Carlos ;
Barr, Eliav ;
Koutsky, Laura A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) :1928-1943
[7]  
*IARC MON WORK GRO, 2005, LANCET, V6, P204
[8]  
IARC Monograph Working Group, 2007, IARC MON EV CARC RIS, V90
[9]   Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial [J].
Paavonen, Jorma ;
Jenkins, David ;
Bosch, F. Xavier ;
Naud, Paulo ;
Salmeron, Jorge ;
Wheeler, Cosette M. ;
Chow, Song-Nan ;
Apter, Dan L. ;
Kitchener, Henry C. ;
Castellsague, Xavier ;
de Carvalho, Newton S. ;
Skinner, S. Rachel ;
Harper, Diane M. ;
Hedrick, James A. ;
Jaisamrarn, Unnop ;
Limson, Genara A. M. ;
Dionne, Marc ;
Quint, Wim ;
Spiessens, Bart ;
Peeters, Pascal ;
Struyf, Frank ;
Wieting, Susan L. ;
Lehtinen, Matti O. ;
Dubin, Gary .
LANCET, 2007, 369 (9580) :2161-2170
[10]   Global cancer statistics, 2002 [J].
Parkin, DM ;
Bray, F ;
Ferlay, J ;
Pisani, P .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) :74-108